CHRISTIANA BRITT: Open Payments
NPI 1013631233 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 51 payments from 13 companies in 2025. Trend: 2023 $478 · 2024 $850 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $235 |
| AstraZeneca Pharmaceuticals LP | 7 | $187 |
| PFIZER INC. | 4 | $82 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lundbeck LLC | 1 | $26 |
Products named: QULIPTA, FARXIGA, REXULTI, AIRSUPRA, VRAYLAR, MOUNJARO, NURTEC ODT, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
